The Lancet, Volume 366, Issue 9487
, Pages 763 - 773, 27 August 2005
doi:10.1016/S0140-6736(05)67182-6Cite or Link Using DOI
Copyright © 2005 Elsevier Ltd All rights reserved.
Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT)
DDT (bis[4-chlorophenyl]-1,1,1-trichloroethane) is a persistent insecticide that was used worldwide from the mid 1940s until its ban in the USA and other countries in the 1970s. When a global ban on DDT was proposed in 2001, several countries in sub-Saharan Africa claimed that DDT was still needed as a cheap and effective means for vector control. Although DDT is generally not toxic to human beings and was banned mainly for ecological reasons, subsequent research has shown that exposure to DDT at amounts that would be needed in malaria control might cause preterm birth and early weaning, abrogating the benefit of reducing infant mortality from malaria. Historically, DDT has had mixed success in Africa; only the countries that are able to find and devote substantial resources towards malaria control have made major advances. DDT might be useful in controlling malaria, but the evidence of its adverse effects on human health needs appropriate research on whether it achieves a favourable balance of risk versus benefit.
This article is made available free of charge, as a service to our users.
Please login to access the full article, or register if you do not yet have a username and password.
Already Registered? Please Login
New to TheLancet.com?
TheLancet.com is the online home of:
- The Lancet
- The Lancet Diabetes & Endocrinology
- The Lancet Global Health
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The Lancet Respiratory Medicine
Please register to access selected articles for free, personalize and interact with this site. Registration is free, takes no more than two minutes, and offers you many benefits.
a Epidemiology Branch, US National Institute of Environmental Health Sciences, P O Box 12233, Research Triangle Park, NC 27709, USA Correspondence to: Dr Walter J Rogan
Access this article on ScienceDirect
Visit ScienceDirect to see if you have access via your institution.
Please login above or register
to use this functionality. Registration is free, takes no more than two minutes, and offers you many benefits.